Oxbryta Recall Announced After Studies Show Sickle Cell Drug’s Risks Outweigh Benefits
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
September 26, 2024 By: Martha Garcia
Pfizer is recalling Oxbryta after at least eight patients died during clinical trials, which sparked a safety review by European drug regulators.
A California woman's lawsuit claims Depo-Provera side effects caused the development of a Grade 1 and Grade 2 Sylvian fissure meningioma that required brain surgery to remove.
Court rejected a motion to dismiss the hair relaxer class actions lawsuits, which seek economic damages for consumers exposed to toxic chemicals in the products, which are now known to increase the risk of uterine cancer, ovarian cancer and other injuries.
A federal judge has announced that lawyers have reached an agreement on the sharing and examination of failed implants at the center of hundreds of Covidien hernia mesh lawsuits.
"*" indicates required fields